News
CVS Health (NYSE:CVS) snapped seven straight sessions of gains as the stock closed 0.92% lower, at $67.09 on Tuesday. The ...
8h
Zacks.com on MSNCVS Surges on Regulatory Relief, Medicare Advantage Push: Time to Buy?CVS surges 53.7% YTD as regulatory relief, strong execution and Medicare Advantage momentum fuel investor confidence.
CVS Health Corporation (NYSE:CVS) is one of the 13 Most Undervalued Retail Stocks to Buy Right Now. On June 5, Wells Fargo ...
Ariel Investments, an investment management company, released its “Ariel Global Fund” first-quarter 2025 investor letter. A ...
CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. Read why CVS ...
Shares of CVS Health Corp. CVS rose 1.67% to $67.46 Friday, on what proved to be an all-around poor trading session for the ...
Health insurance companies have been in the limelight lately after UnitedHealthcare suspended its guidance for the full year citing higher medical costs.
The upbeat quarterly results may be a sign that brighter days are ahead for the CVS – or at least that things may not be as bad as they were last year. The company's stock plummeted more than ...
Ratings for CVS Health CVS were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ratings, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results